These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37351467)

  • 1. The African continent should consider a harmonized consultative and collaborative effort towards coordinated policy and regulatory guidelines across the fields of biotechnology.
    Masehela TS; Barros E
    Front Bioeng Biotechnol; 2023; 11():1211789. PubMed ID: 37351467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD's experience in establishing regulatory systems for medicines and GM crops in Africa.
    Glover B; Akinbo O; Savadogo M; Timpo S; Lemgo G; Sinebo W; Akile S; Obukosia S; Ouedraogo J; Ndomondo-Sigonda M; Koch M; Makinde D; Ambali A
    BMC Proc; 2018; 12(Suppl 8):11. PubMed ID: 30079102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory challenges for GM crops in developing economies: the African experience.
    Nang'ayo F; Simiyu-Wafukho S; Oikeh SO
    Transgenic Res; 2014 Dec; 23(6):1049-55. PubMed ID: 24821674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosafety regulatory frameworks in Kenya, Nigeria, Uganda and Sweden and their potential impact on international R&D collaborations.
    Ongu I; Olayide P; Alexandersson E; Mugwanya Zawedde B; Eriksson D
    GM Crops Food; 2023 Dec; 14(1):1-17. PubMed ID: 36987578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and Challenges for Implementation of the Common Market for Eastern and Southern Africa Policy on Biotechnology and Biosafety.
    Waithaka M; Belay G; Kyotalimye M; Karembu M
    Front Bioeng Biotechnol; 2015; 3():109. PubMed ID: 26284243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosafety Regulatory Reviews and Leeway to Operate: Case Studies From Sub-Sahara Africa.
    Komen J; Tripathi L; Mkoko B; Ofosu DO; Oloka H; Wangari D
    Front Plant Sci; 2020; 11():130. PubMed ID: 32210981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case studies on the use of biotechnologies and on biosafety provisions in four African countries.
    Black R; Fava F; Mattei N; Robert V; Seal S; Verdier V
    J Biotechnol; 2011 Dec; 156(4):370-81. PubMed ID: 21763362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative farmers and regulatory gatekeepers: Genetically modified crops regulation and adoption in developing countries.
    Sinebo W; Maredia K
    GM Crops Food; 2016 Jan; 7(1):1-11. PubMed ID: 26954893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.
    Xue Y; Shang L
    Front Bioeng Biotechnol; 2022; 10():939295. PubMed ID: 35860327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing agricultural gene editing regulation in Latin America: an analysis of how policy windows and policy entrepreneurs shape agricultural gene editing regulatory regimes.
    Zarate S; Cimadori I; Jones MS; Roca MM; Barnhill-Dilling SK
    Front Bioeng Biotechnol; 2023; 11():1209308. PubMed ID: 37362213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Malaysia Ready for Human Gene Editing: A Regulatory, Biosafety and Biosecurity Perspective.
    Kalidasan V; Theva Das K
    Front Bioeng Biotechnol; 2021; 9():649203. PubMed ID: 33777918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of genomic and biobanking research in Africa: a content analysis of ethics guidelines, policies and procedures from 22 African countries.
    de Vries J; Munung SN; Matimba A; McCurdy S; Ouwe Missi Oukem-Boyer O; Staunton C; Yakubu A; Tindana P;
    BMC Med Ethics; 2017 Feb; 18(1):8. PubMed ID: 28153006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Harnessing genomics to improve health in Africa" - an executive course to support genomics policy.
    Smith AC; Mugabe J; Singer PA; Daar AS
    Health Res Policy Syst; 2005 Jan; 3(1):2. PubMed ID: 15667651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging international regulatory framework for biotechnology.
    Komen J
    GM Crops Food; 2012; 3(1):78-84. PubMed ID: 22430851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing for Sustainable Agriculture in Africa.
    Tripathi L; Dhugga KS; Ntui VO; Runo S; Syombua ED; Muiruri S; Wen Z; Tripathi JN
    Front Genome Ed; 2022; 4():876697. PubMed ID: 35647578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from the introduction of genetically engineered crops: relevance to gene drive deployment in Africa.
    Quemada H
    Transgenic Res; 2022 Jun; 31(3):285-311. PubMed ID: 35545692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's evolving biosafety/biosecurity legislations.
    Cao C
    J Law Biosci; 2021; 8(1):lsab020. PubMed ID: 34221436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory frameworks can facilitate or hinder the potential for genome editing to contribute to sustainable agricultural development.
    Mbaya H; Lillico S; Kemp S; Simm G; Raybould A
    Front Bioeng Biotechnol; 2022; 10():959236. PubMed ID: 36246373
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.